Novartis Investigative Site

Ústí nad Labem 40113

0 studies enrolling now · 4 studies all time

What they study most

Cancer, Hidradenitis Suppurativa, Neoplasms, Breast, Primary Prevention of Atherosclerotic Cardiovascular Disease, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa — Running, not enrolling
• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed